Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

STAT+: FDA approves Roivant therapy for rare autoimmune disease

The FDA approved a new medicine from Roivant and its subsidiary Priovant for the treatment of dermatomyositis, a rare autoimmune disease.

STAT+: FDA approves Roivant therapy for rare autoimmune disease

We haven't written up this one. STAT News has the full story — the link below goes straight to it.

Also reported by 2 other outlets

Read the original at statnews.com →

More in Health & Medicine

A startup claims it’s found a drug to make your blood young

I knew I’d officially become a ‘longevity influencer’ this month when a company called Generation Lab reached out to offer me the chance to write about—and even receive—their new rejuvenation…

  • Generation Lab claims injectable drug 1-Generation rejuvenates blood
  • CEO Alina Su and founder Irina Conboy use the treatment privately
  • Company plans larger study with alternative medicine doctors

More from Thursday 27 August →